By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellestis Inc. 

28043 Smyth Drive

Valencia  California  91355  U.S.A.
Phone: 661-775-7480 or 800-519-4627 Fax: 661-775-7479


Company News
QIAGEN N.V. (QGEN) Welcomes Approval of Scheme by Cellestis Inc. (AU:CST) Shareholders 8/4/2011 6:09:33 AM
Cellestis Inc. (AU:CST) Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis 7/25/2011 6:03:34 AM
QIAGEN N.V. (QGEN) Hikes Offer to Acquire Cellestis Inc. (AU:CST) by 7 Percent 7/11/2011 6:35:48 AM
QIAGEN Inc. (QGEN) Makes Proposal to Acquire Australian Diagnostics Company Cellestis Inc. (AU:CST) for $355 Million 4/4/2011 6:39:22 AM
Cellestis Inc. (AU:CST) Continues its Strong Growth, Despite the Strength of the Aussie Buck 2/14/2011 9:28:48 AM
Cellestis Inc. (AU:CST) Continues to Increase Profit and Sales as Worldwide Recognition of QuantiFERON-TB Testing Grows - Full Year Financial 8/23/2010 8:08:02 AM
Cellestis Inc. (AU:CST) Reports Record Profit And Sales – Full Year Financial Results 2009 8/25/2009 12:48:18 PM
Cellestis Inc. (AU:CST) Release: Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy 11/14/2007 7:55:30 AM
Cellestis Inc. (AU:CST) Receives FDA Approval for Blood Test for Detecting Tuberculosis 10/12/2007 6:10:42 AM
FischerHealth Release: County Of San Francisco First In Country To Diagnose Tuberculosis Infection With QuantiFERON(R)-TB GOLD10/19/2005 5:12:38 PM